From August 7 to 10, 2024, the 21st Endocrinology Academic Conference of the Chinese Medical Association was held at the Suzhou International Expo Center. In the exhibition area, TUL, as a well-known domestic biopharmaceutical company specializing in diabetes care, showcased its latest R&D achievements and products in the field of antidiabetic biologics, attracting significant attention from experts in the field of endocrinology.